Please login to the form below

Not currently logged in
Email:
Password:

RSA boosts its German speaking divisions

Appoints Andreas Reimer and Ji Kwon

RSA Jo KwonRSA has appointed Andreas Reimer and Ji Kwon (pictured) to strengthen its operations in Germany, Austria and Switzerland (DACH).

Reimer joins the life sciences executive search and executive interims firm's Frankfurt office as a senior consultant.

He has been an executive search consultant in the sector since 1992 and prior to joining RSA he served as client partner and co-head of the global sector of excellence at Alexander Hughes.

Before that he worked as an executive search consultant in life sciences for more than 15 years with three other leading local and international firms.

Meanwhile Ji Kwon joins RSA as an associate consultant and will also be based in its Frankfurt offices.

Prior to joining RSA, she was employed Odgers Berndtson, where she worked on numerous searches within Life Sciences. Kwon also previously worked for a Korean boutique agency with a focus on finding roles in consumer electronics and the automotive industry.

Kristian Juergensen, head of DACH and managing director at RSA Germany, said: “Both appointments reflect an extension of RSA's abilities, especially in diagnostics and medical devices.
 
“We had a very strong year last year, and this one is starting well, with a large multi-assignment contract already won. This has allowed us to grow in specific areas.”

30th April 2015

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Dimitri Azzopardi
Case-study for thalassaemia: Dimitri Azzopardi
An in-depth look at beta thalassaemia for Rare Disease Day...
Delivering change through better rare disease communications
OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes....
Interim analysis clinical trials
Assessing the value of interim analyses in clinical trials
Why its important and when its needed...

Infographics